Biohaven initiated at overweight at JP Morgan on neurological targets [Seeking Alpha]
Biohaven Ltd. Common Shares (BHVN)
Last biohaven ltd. common shares earnings: 2/25 04:45 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.biohavenpharma.com
Company Research
Source: Seeking Alpha
Biohaven initiated at overweight at JP Morgan on neurological targetsJan. 04, 2023 3:48 PM ETBiohaven Ltd. (BHVN)PFEBy:Jonathan BlockSA News EditorozgurdonmazJP Morgan has started Biohaven (NYSE:The firm has a $23 price target (~70% upside based on Monday's close).Shares areup 8%Analyst Tessa Romero said she is particularly excited about BHV-7000 for focal seizures as discussions with key opinion leaders indicate there is a significant unmet medical need for the condition.Although there is no clinical data yet for BHV-7000, "we believe that proof-of-concept has already been established for the asset in focal epilepsy given its comparable mechanism of action to ezogabine as Kv7 activators."Looking ahead to the next six to 12 months, Romero said she is anticipating a phase 1 study update evaluating BHV-7000 in healthy volunteers in the first half of the year and the beginning of a phase 2/3 trial for BHV-7000 in focal onset seizures in the second half.
Show less
Read more
Impact Snapshot
Event Time:
BHVN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BHVN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BHVN alerts
High impacting Biohaven Ltd. Common Shares news events
Weekly update
A roundup of the hottest topics
BHVN
News
- Biohaven Ltd. (NYSE: BHVN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- Biohaven Announces Pricing of $230 Million Public Offering of Common Shares [Yahoo! Finance]Yahoo! Finance
- Biohaven Announces Pricing of $230 Million Public Offering of Common SharesPR Newswire
- Biohaven announces proposed underwritten offering of shares [Seeking Alpha]Seeking Alpha
- Biohaven Announces Proposed Public Offering of Common SharesPR Newswire
BHVN
Earnings
- 11/14/23 - Miss
BHVN
Sec Filings
- 4/17/24 - Form 424B5
- 4/15/24 - Form 8-K
- 4/5/24 - Form 4
- BHVN's page on the SEC website